Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

L.G. van Baarsen; S. Vosslamber; M. Tijssen; J.M. Baggen; d., V van; J. Killestein; C.T.M. van der Pouw Kraan; C.H. Polman; C.L. Verweij

doi:10.1371/journal.pone.0001927

Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

L.G. van Baarsen, S. Vosslamber, M. Tijssen, J.M. Baggen, d., V van, J. Killestein, C.T.M. van der Pouw Kraan, C.H. Polman, C.L. Verweij

Research output: Contribution to journal › Article › Academic › peer-review

56 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	e1927
Journal	PLoS ONE
Volume	3
Issue number	4
DOIs	https://doi.org/10.1371/journal.pone.0001927
Publication status	Published - 2008

Access to Document

10.1371/journal.pone.0001927

289352Final published version, 303 KB

Cite this

van Baarsen, L. G., Vosslamber, S., Tijssen, M., Baggen, J. M., van, D. . V., Killestein, J., van der Pouw Kraan, C. T. M., Polman, C. H., & Verweij, C. L. (2008). Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients. PLoS ONE, 3(4), e1927. https://doi.org/10.1371/journal.pone.0001927

@article{97299801a71b41b7bc16a99471b8018b,

title = "Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients",

author = "{van Baarsen}, L.G. and S. Vosslamber and M. Tijssen and J.M. Baggen and van, {d., V} and J. Killestein and {van der Pouw Kraan}, C.T.M. and C.H. Polman and C.L. Verweij",

year = "2008",

doi = "10.1371/journal.pone.0001927",

language = "Undefined/Unknown",

volume = "3",

pages = "e1927",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "4",

}

TY - JOUR

T1 - Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

AU - van Baarsen, L.G.

AU - Vosslamber, S.

AU - Tijssen, M.

AU - Baggen, J.M.

AU - van, d., V

AU - Killestein, J.

AU - van der Pouw Kraan, C.T.M.

AU - Polman, C.H.

AU - Verweij, C.L.

PY - 2008

Y1 - 2008

U2 - 10.1371/journal.pone.0001927

DO - 10.1371/journal.pone.0001927

M3 - Article

C2 - 18382694

SN - 1932-6203

VL - 3

SP - e1927

JO - PLoS ONE

JF - PLoS ONE

IS - 4

ER -